New approach methods to improve human health risk assessment of thyroid hormone system disruption–a PARC project

Archive ouverte

Ramhøj, Louise | Axelstad, Marta | Baert, Yoni | Cañas-Portilla, Ana, I | Chalmel, Frédéric | Dahmen, Lars | de la Vieja, Antonio | Evrard, Bertrand | Haigis, Ann-Cathrin | Hamers, Timo | Heikamp, Kim | Holbech, Henrik | Iglesias-Hernandez, Patricia | Knapen, Dries | Marchandise, Lorna | Morthorst, Jane, E | Nikolov, Nikolai, Georgiev | Nissen, Ana, C V E | Oelgeschlaeger, Michael | Renko, Kostja | Rogiers, Vera | Schüürmann, Gerrit | Stinckens, Evelyn | Stub, Mette, H | Torres-Ruiz, Monica | van Duursen, Majorie | Vanhaecke, Tamara | Vergauwen, Lucia | Wedebye, Eva, Bay | Svingen, Terje

Edité par CCSD ; Frontiers Media -

International audience. Current test strategies to identify thyroid hormone (TH) system disruptors are inadequate for conducting robust chemical risk assessment required for regulation. The tests rely heavily on histopathological changes in rodent thyroid glands or measuring changes in systemic TH levels, but they lack specific new approach methodologies (NAMs) that can adequately detect TH-mediated effects. Such alternative test methods are needed to infer a causal relationship between molecular initiating events and adverse outcomes such as perturbed brain development. Although some NAMs that are relevant for TH system disruption are available-and are currently in the process of regulatory validation-there is still a need to develop more extensive alternative test batteries to cover the range of potential key events along the causal pathway between initial chemical disruption and adverse outcomes in humans. This project, funded under the Partnership for the Assessment of Risk from Chemicals (PARC) initiative, aims to facilitate the development of NAMs that are specific for TH system disruption by characterizing in vivo mechanisms of action that can be targeted by in embryo/in vitro/in silico/in chemico testing strategies. We will develop and improve human-relevant in vitro test systems to capture effects on important areas of the TH system. Furthermore, we will elaborate on important species differences in TH system disruption by incorporating non-mammalian vertebrate test species alongside classical laboratory rat species and human-derived in vitro assays.

Suggestions

Du même auteur

Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment

Archive ouverte | de Castelbajac, Thalia | CCSD

International audience. New approach methodologies (NAMs) have the potential to become a major component of regulatory risk assessment, however, their actual implementation is challenging. The European Partnership f...

Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals—The ATHENA Project

Archive ouverte | Kortenkamp, Andreas | CCSD

International audience. The test methods that currently exist for the identification of thyroid hormone system-disrupting chemicals are woefully inadequate. There are currently no internationally validated in vitro ...

PFOS-induced thyroid hormone system disrupted rats display organ-specific changes in their transcriptomes

Archive ouverte | Davidsen, Nichlas | CCSD

International audience. Perfluorooctanesulfonic acid (PFOS) is a persistent anthropogenic chemical that can affect the thyroid hormone system in humans and animals. In adults, thyroid hormones (THs) are regulated by...

Chargement des enrichissements...